Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003093662 | SCV003470929 | likely benign | not provided | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003085818 | SCV003564373 | uncertain significance | Inborn genetic diseases | 2021-09-27 | criteria provided, single submitter | clinical testing | The c.2668C>G (p.P890A) alteration is located in exon 30 (coding exon 29) of the COL4A4 gene. This alteration results from a C to G substitution at nucleotide position 2668, causing the proline (P) at amino acid position 890 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV003093662 | SCV005415181 | uncertain significance | not provided | 2024-05-20 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Occurs in the triple helical domain at the Y position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the Y position is not a common mechanism of disease |
Fulgent Genetics, |
RCV005028201 | SCV005653961 | uncertain significance | Autosomal recessive Alport syndrome; Hematuria, benign familial, 1 | 2024-02-08 | criteria provided, single submitter | clinical testing |